FAIRFIELD, Conn., Nov. 20, 2013 /PRNewswire via COMTEX/ -- Competitive Technologies, Inc., (otcqx:CTTC) (CTI), a pain mitigation biotechnology company, reported results for three months and nine months ended September 30, 2013.
Three Months Ended September 30, 2013
Revenue from the sale and shipment of Calmare® pain therapy medical devices (Devices), in the three months ended September 30, 2013 decreased 7% or $21,000 to $290,000 as compared with $311,000 for the comparable quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
